TABLE 1.
Fatty acid composition (mg/4-g daily dose) of the 3 study interventions1
| EPA+DHA |
|||
| Fatty acid | 0 g/d | 0.85 g/d | 3.4 g/d |
| Palmitic, 16:0 | 464 | 348 | 1 |
| Stearic, 18:0 | 73 | 55 | 2 |
| Oleic, 18:1n−9 | 1121 | 843 | 10 |
| Linoleic, 18:2n−6 | 2240 | 1681 | 2 |
| Eicosadienoic, 20:2n−6 | 1 | 18 | 70 |
| Arachidonic, 20:4n−6 | 0 | 15 | 62 |
| EPA, 20:5n−3 | 0 | 486 | 1944 |
| Docosapentaenoic acid (n−3), 22:5n−3 | 0 | 35 | 141 |
| Docosapentaenoic acid (n−6), 22:5n−6 | 0 | 12 | 48 |
| DHA, 22:6n−3 | 0 | 421 | 1686 |
1
Values were calculated from independent analysis of fatty acid composition of a sample of active and placebo capsules (only fatty acids detected ≥1% of total fatty acids for either active treatment or placebo capsules are shown). EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid.